October 18, 2016 / 11:21 AM / in 9 months

BRIEF-Actinium Pharmaceuticals granted orphan designation for Iomab-B

1 Min Read

Oct 18 (Reuters) - Actinium Pharmaceuticals Inc :

* Actinium Pharmaceuticals granted orphan designation from the European Medicines Agency for Iomab-B Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below